GB2082922A - Nasal protective device and method - Google Patents

Nasal protective device and method Download PDF

Info

Publication number
GB2082922A
GB2082922A GB8115650A GB8115650A GB2082922A GB 2082922 A GB2082922 A GB 2082922A GB 8115650 A GB8115650 A GB 8115650A GB 8115650 A GB8115650 A GB 8115650A GB 2082922 A GB2082922 A GB 2082922A
Authority
GB
United Kingdom
Prior art keywords
nose
splint
nubs
nasal
spring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB8115650A
Other versions
GB2082922B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAKE NORMAN MARION
Original Assignee
LAKE NORMAN MARION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAKE NORMAN MARION filed Critical LAKE NORMAN MARION
Publication of GB2082922A publication Critical patent/GB2082922A/en
Application granted granted Critical
Publication of GB2082922B publication Critical patent/GB2082922B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A62LIFE-SAVING; FIRE-FIGHTING
    • A62BDEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B9/00Component parts for respiratory or breathing apparatus
    • A62B9/06Mouthpieces; Nose-clips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Management (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Business, Economics & Management (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Protective method and apparatus for the nasal passages comprises a U- shaped wire spring each leg of which is frictionally held within an ellipsoidal-like nub for closing the nose by pressing in on its sides, thereby raising the temperature of the nasal passages. <IMAGE>

Description

SPECIFICATION Nasal protective method and device This invention relates to an improvement in nasal protectors for the protection of the mucous membranes of the nasal passages.
The prior art teaches the use of numerous nasal protective devices, but does not teach the use of a device that closes off the nasal passages for the purpose of creating in the nose nasal passage a condition substantially equivalent to inflammation, the natural defensive reaction to irritation.
U.S. Patent No. 2,317,236 is typical of the prior art wherein a nose clip closes the nasal passages but under conditions that will not develop the natural defensive reaction of inflammation.
The apparatus of the invention is preferably a nasal splint having a U-shaped wire spring with an ellipsoidal-like shaped nub on each leg of the spring. Each nub is rotationally and longitudinally adjustable with regard to each leg of the spring to adjust the splint to human noses of different sizes.
The method of using the inventive device above requires that the splint be positioned on the nose to close off the nasal passages and exert a firm pressure on the septum for a period of 30 minutes of more causing the nasal temperature to rise sufficiently to create a condition in the nose substantially equivalent to inflammation, the natural defensive reaction to irritation but without the pain and suffering of inflamed and swollen membranes.
Brief Description of the Drawing Figure 1 illustrates the nasal splint in use, Figure 2 is a perspective view of the nasal splint, and Figure 3 is a cross-sectional view of the ends of the nasal splint.
Description of the Preferred Embodiments This invention relates to an improvement in nasal protectors and has for its object the protection of the mucous membranes of the nasal - passages. To this end inhalation of airborne irritants entering the nose are trapped and minimized; reactions to a stimulus (which are manifested by sneezing) are inhibited, and "inflammation" (the natural defensive reaction to irritation) is simulated.
Toward this objective (1) the nose of the human is closed to a degree sufficient to trap and minimize inhalation of airborne irritants entering the nose but insufficient to block breathing and watery secretions therefrom, (2) the nose is wholly closed off by exerting a firm pressure on its sides for 30 minutes or more (during which time forceful attempts to inhale through nose should be exercised) to inhibit the explosive actions of sneezing by control of voluntary muscles of the nose, and (3) the nasal temperature is caused to rise sufficient to create a condition substantially equivalent to inflammation (inflamed and swollen membranes), the natural defensive mechanism of the nose. Thus precluding or abating the inflammatory process whereby the evils therefrom are arrested or alleviated.
The means employed for implementing this invention is advantageously a small improved nasal splint comprising a resilient and adjustable music wire spring 2 (ranging in diameter about 0.030 of an inch) each leg 4 and 6 of which is embedded along the central axis holding by friction an ellipsoidal-like nub 8 and 10, preferably of polyethylene, having a certain elastic quality to permit adjustment of each nub along and around each leg of the spring, thus adapting the nasal splint to conform with comfort to the size and shape of the nose.
This invention has two unique improvements over that of my previous Patent No. 4,033,342 issued July 5, 1977. In that patent, each leg of the U-shaped spring was rigidly embedded in a different one of the nubs, whereas in this improved invention, each nub is held to a different leg of the spring only by friction but with sufficient gripping power thus providing for easy adjustment, more comfortto the wearer and adaptability to conform with the shape and size of nose.
The second and major improvement in this invention is the period of time of closing off the nasal passages. in my previous Patent No.
4,033,342, the time period of closing the nose was only two or three minutes for the purpose of inhibiting sneezing. Whereas this improved invention requires closing off the nose for a period of 30 minutes or more causing a rise in nasal temperature and thus creating a temporary condition in the nose substantially equivalent to inflammation, the natural defensive mechanism of the nose.
During the fall, winter and spring seasons particularly, the nasal mucous membranes of the individual are subjected to attack by countless airborne irritants which are constantly being breathed into the nose, some of which are often infectious. Many of these agents, after entering the nose, are conveyed by the mucous blanket back to the throat where they are swallowed and rendered harmless. But, unfortunately, some succeed in escaping this movement to the throat and, instead, land in and attack the membranes.
Irritation then begins and evils generate and develop. When this condition is reached, the individual soon succumbs to the explosive actions of sneezing - and as sneezing is well known to irritate the nasal mucous membranes - the problem then becomes compounded, causing a rapid development of the inflammatory process which results in nasal blockage and in other complications. When an irritating agent attacks the nasal mucosa, irritation therefrom ensues.
Two things then promptly occur, (1) the small vessels of the nasal membranes dilate and watery secretions therefrom are increased, and (2) nature reacts to this irritation by sneezing which appears to be nature's way of removing the agent that is causing the irritation. If the causative agent is noninfectious, sneezing will often dislodge it and the secretions, which are part of nature's defense cycle, can wash it back in the throat to be swallowed. However, the non-infectious invader can often become so entrenched in the nasal mucosa that sneezing will fail to dislodge it, and along with its continued irritation coupled with that from sneezing, complications can surely be expected to follow.If, on the other hand, the irritation is being caused by an infectious agent, a different situation develops, that is, the agent has succeeded in gaining entrance to a living cell from which it gains protection from being dislodged by sneezing. So here again, an invader is inflicting irritation and setting the stage for complications to follow, which in this case are perhaps more serious. In both of these cases, irritation of the nasal passages causes the inflammatory process to develop, resulting in nasal blockage and inflamed membranes, but when the inflammatory process is caused by an infectious agent, favorable conditions are thereby created under which this infectious agent may multiply and produce results that are injurious.
An object of this invention first of all is to (1) reduce to a minimum the inhalation of irritating agents entering the nose, (2) inhibit the reactions of sneezing to these irritants which escape the mucous blanket and initiate irritation in the nasal mucosa, and (3) simulate inflammation, the natural defensive reaction to irritation.
From my own observations and clinical studies by research scientists, the average nasal disorder generally called a common head cold or hay fever is diagnosed usually only by guess. But one thing is quite certain, the symptoms are virtually the same. Ths disorder is generally sensed by repeated spells of sneezing, water dropping from nose and, at times, a slight scratchy feeling in the throat. During the first 36 to 48 hours, all the usual painful symptoms are developing until the peak of nasal obstruction is finally reached and then something significant happens. That is, all the symptoms are brought to a halt and begin shortly thereafter to subside progressively toward zero, but it takes five or more days for all symptoms to disappear.
What brought about this phenomenon ? It cannot be credited to antibodies because more than one clinical study has discovered that the antibodies present in such cases are not due to the infecting virus. So the overcoming of such illnesses is left in the hands of mother nature to develop inflammation (heat and swelling) as the last resort to end such disorders. And those two vital conditions, heat (increased nasal temperature) and swelling (nasal blockage), provide the defensive action which ultimately overcomes nasal disorders such as hay fever and common head colds. Thus, when the nose is closed with this nasal splint, nasal blockage occurs and the nasal temperature rises, thereby simulating or mimicking inflammation, the natural defensive mechanism, of the nose.
In brief, this improved method of prolonging the time of closing off the nasal passages is precisely the difference between failure and success in preventing the inflammatory process and arresting nasal disorders. Hence, when repeated spells of sneezing occur, the nasal splint should be adjusted and applied to close off the nasal passages and to exert a firm pressure on the nasal septum (position 1, Fig. 1); and while holding this position for a period of 30 minutes of more, forceful attempts to inhale through the nose should be exercised. At the end of the said period, adjust the splint to a degree only sufficient to breath comfortably through the nose, yet retain a degree of constriction in the nasal passages (position 1', Fig. 1). In this adjusted position of the nasal splint, it will trap and minimize inhalation of irritants entering the nose and enhance its filtering system.
It can be worn in this position as long as desired with safety and little or no discomfort.
It should be noted that when the nasal mucous membranes are under attack, watery secretions of the nose occur. By actual experience, I have discovered that blotting these secretions rather than blowing the nose has proved most helpful toward achieving the objective of the invention.
Furthermore, use of this nasal splint will operate as a deterrent to nose blowing.
This invention resides not merely in using a nasal clip, but in making a nasal protective splint adaptable for a new and inventive use. The prime object of the invention is to fulfill a health need long desired but never attained which fact is manifested by its absence of availability for public benefit. My invention is novel since it is out of the ordinary and unobvious because it is insufficiently evident as to arrest attention.
The nasal splint has striking properties over conventional nasal protective devices, namely, (1) practicability (more acceptable for public use); (2) less unsightly to wear; (3) comfortable to wear; (4) no health hazard; (5) manufacturing costs will be at a minimum since it comprises only two simple parts; (6) a lower price level can be created by making volume production easier.
In two tests to determine rise in temperature inthe nasal passages, the following temperature/times were recorded: Test 1 Time Nose Closed Off Temperature in (mins.) Nasal Passage 0 33.50C. (92.30 F.) 5 35.8 OC. (96.40 F.) 10 36.4 C. (97.50 F.) 15 36.50C. (97.7oF.) 20 36.5 C. (97.70F.) 25 36.70C. (98.060F.) 30 36.7 OC. (98.060 F.) Test 2 Time Nose Closed Off Temperature in (mins.) Nasal Passage 0 330C. (91.40F.) 5 35.80C. (96.40 F.) 10 36.40C. (97.50 F.) 15 36.60C. (97.80F.) 20 36.60C. (97.80F.) During both tests, the temperature in the mouth was 97.40F. The average normal temperature in the nose is330C. (91.40F.).The higher temperatures are in the range of inflamed nasal mucous membranes, a vital condition of inflammation.
The present invention accordingly also provides a nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a plastic nub preferably of polyethylene with certain elasticity for holding the nub only by friction, said spring of the U-shaped splint pressing the nubs in on the sides of the nose in the area just above the alae, this being done to the extent of closing the nose sufficient to trap and minimize inhalation of airborne irritants entering the nose, but insufficient to block breathing and watery secretions therefrom when threatened by harmful material entering the nasal passages.
More especially, the invention provides a nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a plastic nub preferably of polyethylene with certain elasticity for holding the nub only by friction, said spring of the U-shaped splint pressing the nubs in on the sides of the nose in the area defined by the portion above the alae and by the upper portion of the alae, this being done to the extent of closing off the nasal passages by exerting a firm pressure on the septum for a period of 30 minutes and more if the attack by foreign material is severe, and immediately after the lapse of said.time period, relocate the splint to the extent of closing the nose sufficient to trap and minimize inhalation of airborne irritants entering the nose, but insufficient to block breathing and watery secretions therefrom, and wear in that position as long as desired to trap and minimize harmful material entering the nasal passages.

Claims (6)

1. An improved process of employing a particular nasal splint for helping the human nose maintain its mucous membranes in good condition said splint comprising a U-shaped wire spring for straddling the nose and having two nubs each of ellipsoidal-like shape, each leg of the U-shaped spring being embedded in and along the central axis of a different one of the nubs, but holding the same only by friction, thus permitting each nub rotational and longitudinal adjustment relative to each leg of the spring and said process comprising locating the splint such that the spring of the splint presses the nubs in on the sides of the nose in an appropriate area defined by the portion above the alae, this being done to a degree sufficient to trap and minimize inhalation of airborne irritants entering the nose, but insufficient to block breathing and watery secretions therefrom, thus enhancing the nasal filtering system and helping the nose protect against the numerous irritants breathed into the nose during certain seasons of the year.
2. An improved process of employing a particular nasal splint for helping the human maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two nubs each of ellipsoidal-like shape, each leg of the U-shaped spring being embedded in and along the central axis of a different one of the nubs, but holding the same only by friction, thus permitting each nub rotational and longitudinal adjustment relative to each leg of the spring. and said process comprising locating the splint such that the spring of the splint presses the nubs in on the sides of the nose in an appropriate area defined by the portion above the alae and by the upper portion of the alae, this being done to the extent of closing off the nasal passages and exerting a firm pressure on the septem for a period of 30 minutes or more during which time forceful attempts to inhale through the nose should be exercised, thus helping control the compound explosive reactions of sneezing, and causing the nasal temperature to rise sufficient to create a condition in the nose substantially equivalent to "inflammation", the natural defensive reaction to irritation but without the pain and suffering of inflamed and swollen membranes, thereby precluding or abating the inflammatory process whereby the attendant evils are arrested or alleviated, and then after 30 minutes or more relocating said splint with respect to the nose such that the spring of the splint presses the nubs in on the sides of the nose in the area defined by the portion above the alae to a degree sufficient to trap and minimize inhalation of airborne irritants entering the nose but insufficient to block breathing and watery secretions therefrom, thus enhancing the nasal filtering system and helping the nose protect against the numerous irritants breathed into the nose during certain seasons of the year.
3. A nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two nubs, each of ellipsoidal-like shape, each leg of the U-shaped spring being embedded in and along a different one of the nubs, but holding the same only by friction, thereby each nub being capable of rotational movement relative the longitudinal axis of the leg and also capable of sliding movement along the longitudinal axis of the leg whereby the two nubs are adjustable with regard to each leg of the U-shaped spring to permit the nubs to be adjusted to human noses of different sizes.
4. A splint for helping the human nose maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a nub of plastics material having some elasticity for holding the nub only by friction, said spring of the U-shaped splint being capable of pressing the nubs in on the sides of the nose in the area just above the alae to the extent of closing the nose sufficient to trap and minimize inhalation of airborne irritants entering the nose but insufficient to block breathing and watery secretions therefrom.
5. A nasal splint for helping the human nose maintain its mucous membranes in good condition, said splint comprising a U-shaped wire spring for straddling the nose and having two ellipsoidal-like nubs each of circular outline with two convex side faces, each leg of the U-shaped spring being embedded in a thermoplastics nub with a certain degree of elasticity for holding the nub only by friction, said spring of the U-shaped splint being capable of pressing the nubs in on the sides of the nose in the area defined by the portion above the alae and by the upper portion of the alae to the extent of closing off the nasal passages by exerting a firm pressure on the septum for a period of upwards 30 minutes and immediately after the lapse of said time period, relocatable to the extent of closing the nose sufficient to trap and minimize inhalation of airborne irritants entering the nose, but insufficient to block breathing and watery secretions therefrom, and wearable in that position as long as desired, to trap and minimize harmful material entering the nasal passages.
6. A splint, substantially as hereinbefore described with reference to and as illustrated by any one or more of the accompanying drawings.
GB8115650A 1980-09-02 1981-05-21 Nasal protective method and device Expired GB2082922B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18321480A 1980-09-02 1980-09-02

Publications (2)

Publication Number Publication Date
GB2082922A true GB2082922A (en) 1982-03-17
GB2082922B GB2082922B (en) 1984-11-28

Family

ID=22671933

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8115650A Expired GB2082922B (en) 1980-09-02 1981-05-21 Nasal protective method and device

Country Status (1)

Country Link
GB (1) GB2082922B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363575A (en) * 2000-04-13 2002-01-02 Nicola Herron A Nose Clip

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363575A (en) * 2000-04-13 2002-01-02 Nicola Herron A Nose Clip

Also Published As

Publication number Publication date
GB2082922B (en) 1984-11-28

Similar Documents

Publication Publication Date Title
US4573461A (en) Nasal sealer and filter
EP0967930B1 (en) Intraoral semi-custom discluder device
US3905335A (en) Nasal air filter
US5795150A (en) Intraoral semi-custom discluder device and method
US4445508A (en) Nasal protective method and device
US20110307039A1 (en) Device, method and system for treatment of sinusitis
US5085584A (en) Intraoral discluder device and method
Fisher et al. Direct and collateral effects of restraints and restraint fading
WO2002089698A3 (en) Animal training method and device
US4033342A (en) Nasal protective splint
US2064986A (en) Nose clip
CN111068152A (en) Dilator for aromatic substance
Nissani Can taste aversion prevent bruxism?
Klaeger-Manzanell et al. Two step recovery of vision in the amblyopic eye after visual loss and enucleation of the fixing eye.
JPH0626615B2 (en) Pollen protector
CA1142828A (en) Nasal protective method and device
GB2082922A (en) Nasal protective device and method
CN208096081U (en) A kind of Respiratory Medicine outpatient service face mask type transparent mask
WO2018127878A2 (en) Thermal massager mask for migraine relief
WO2022054108A1 (en) Respiratory moisture-regulating face four-layer mask with full attachment on the face
WO2019213037A1 (en) Nasal mucosa heating and occlusion eyewear
US5388592A (en) Protective barrier
CA1113331A (en) Nasal protective splint
US20080006267A1 (en) Method and device for treating bruxism while sleeping
BR0311180A (en) Methods for treating respiratory diseases and conditions using a selective inhibitor of inos

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee